Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
INCREASE FUNDING - MODIFICATION TO OPTION YEAR FOR ADDITIONAL REGENTS AND COVID TESTING SUPPLIES is a federal award for 255-Network Contract Office 15 (36C255) held by Biofire Diagnostics, LLC. Estimated value $2.7M ($-317,282.3 obligated). Current period of performance ends Sep 30, 2021 (potential Sep 30, 2023). Place of performance: SALT LAKE CITY UT.
INCREASE FUNDING - MODIFICATION TO OPTION YEAR FOR ADDITIONAL REGENTS AND COVID TESTING SUPPLIES
Recompete timing
PublicCurrent PoP ended Sep 30, 2021 (1786 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordBiofire Diagnostics, LLC — $14.7M obligated across 200 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25520N0488?
36C25520N0488 (Increase funding - modification to OPTION) is a 255-Network Contract Office 15 (36C255) award with a potential value of $2.7M, currently held by Biofire Diagnostics, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C255-20-N-0488?
36C255-20-N-0488 is the dashed form of PIID 36C25520N0488 (Increase funding - modification to OPTION), held by Biofire Diagnostics, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25520N0488?
255-Network Contract Office 15 (36C255) awarded 36C25520N0488 to Biofire Diagnostics, LLC (potential $2.7M).
Who is the incumbent on 36C25520N0488?
Biofire Diagnostics, LLC is the incumbent with $14.7M across 200 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2021.
When does Biofire Diagnostics, LLC’s 36C25520N0488 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.